WANDA BEARING
920002
HENDERA
831152
LINGOOD
833284
4
WUHAN LAND
830779
5
TECHVISION
832876
US Stock MarketDetailed Quotes
TGTX TG Therapeutics
- 29.340
- +0.130+0.45%
Close Feb 26 16:00 ET
4.57BMarket Cap-293.40P/E (TTM)
29.955High29.000Low1.30MVolume29.280Open29.210Pre Close38.28MTurnover0.90%Turnover Ratio326.00P/E (Static)155.67MShares36.84052wk High23.78P/B4.25BFloat Cap12.93052wk Low--Dividend TTM144.91MShs Float149414.006Historical High--Div YieldTTM3.27%Amplitude0.956Historical Low29.449Avg Price1Lot Size
TG Therapeutics News
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WEISS MICHAEL S
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Power Sean A
TG Therapeutics | 8-K: Current report
TG Therapeutics | SCHEDULE 13G/A: Others
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Power Sean A
TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
TG Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Darwin Global Management, Ltd.(0%),Dr. Abhishek Trehan(0%), etc.
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lonial Sagar
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Charney Laurence N
TG Therapeutics | 144/A: Others
TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Echelard Yann
TG Therapeutics | 10-Q: Q3 2024 Earnings Report
TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
TG Therapeutics | 8-K: ® TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI (ublituximab-xiiy) Full Year Revenue Guidance
TG Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(14.2%)
TG Therapeutics | 10-Q: Q2 2024 Earnings Report
TG Therapeutics | 10-K/A: Annual report (Amendment)
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!